Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies

Open access

Abstract

Background: Converging lines of evidence implicate an important role for the immune system in schizophrenia. Microglia are the resident immune cells of the central nervous system and have many functions including neuroinflammation, axonal guidance and neurotrophic support. We aimed to provide a quantitative review of in vivo PET imaging studies of microglia activation in patients with schizophrenia compared with healthy controls. Methods: Demographic, clinical and imaging measures were extracted from each study and meta-analysis was conducted using a random-effects model (Hedge's g ). The difference in 18-kDa translocator protein (TSPO) binding between patients with schizophrenia and healthy controls, as quantified by either binding potential (BP) or volume of distribution ( V T ), was used as the main outcome. Sub-analysis and sensitivity analysis were carried out to investigate the effects of genotype, ligand and illness stage. Results: In total, 12 studies comprising 190 patients with schizophrenia and 200 healthy controls met inclusion criteria. There was a significant elevation in tracer binding in schizophrenia patients relative to controls when BP was used as an outcome measure, (Hedge's g = 0.31; p = 0.03) but no significant differences when V T was used (Hedge's g = −0.22; p = 0.29). Conclusions: In conclusion, there is evidence for moderate elevations in TSPO tracer binding in grey matter relative to other brain tissue in schizophrenia when using BP as an outcome measure, but no difference when VT is the outcome measure. We discuss the relevance of these findings as well as the methodological issues that may underlie the contrasting difference between these outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0033291718003057

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Flowchart showing the inclusion of studies for the meta-analysis.
Fig. 1. Flowchart showing the inclusion of studies for the meta-analysis.CC BY · PubMed Central
Fig. 2. Forest plot showing the effect sizes for in vivo microglia measures in schizophrenia patients compared with controls as measured by translocator protein binding potential (BP) in total grey matter. There was a significant elevation in schizophrenia with an effect size = 0.31 (p = 0.03).
Fig. 2. Forest plot showing the effect sizes for in vivo microglia measures in schizophrenia patients compared with controls as measured by translocator protein binding potential (BP) in total grey matter. There was a significant elevation in schizophrenia with an effect size = 0.31 (p = 0.03).CC BY · PubMed Central
Fig. 3. Forest plot showing effect sizes for in vivo microglia measures in schizophrenia patients compared with controls as measured by volume of distribution of translocator radiotracer (VT) in total grey matter. There were no significant changes in patients compared with controls (effect size = −0.22, p = 0.296).
Fig. 3. Forest plot showing effect sizes for in vivo microglia measures in schizophrenia patients compared with controls as measured by volume of distribution of translocator radiotracer (VT) in total grey matter. There were no significant changes in patients compared with controls (effect size = −0.22, p = 0.296).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 224

Metadata

Authors
Marques, T. R., Ashok, A. H., Pillinger, T., Veronese, M., Turkheimer, F. E., Dazzan, P., Sommer, I. E. C., & Howes, O. D.
Affiliations
  • MRC London Institute of Medical Sciences (GB)
  • King's College London (GB)
  • University Medical Center Utrecht (NL)
Corresponding author
Marques, Tiago Reis
Venue
Psychological Medicine
Published
2018-10-25
Volume
49
Issue
13
Pages
2186-2196
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W2898554771
Cited by
213
References
66
Citations by year
2026: 15 · 2025: 19 · 2024: 27 · 2023: 31 · 2022: 36 · 2021: 34 · 2020: 31 · 2019: 18 · 2018: 2
FWCI
3.23
Type
journal article
Language
en
Open access
Locations
  • Psychological Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
Medical Research Council (MR/N026063/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
schizophrenia, neuroinflammation, microglial activation, translocator protein (TSPO), positron emission tomography, binding potential, volume of distribution, grey matter
MeSH terms
Blood Pressure, Humans, Inflammation, Schizophrenia, Microglia, Receptors, GABA, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies. https://app.cochat.ai/papers/10.1017/s0033291718003057
The paper
Marques, T. R., Ashok, A. H., Pillinger, T., Veronese, M., Turkheimer, F. E., Dazzan, P., Sommer, I. E. C., & Howes, O. D. (2019). Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies. Psychological Medicine. https://doi.org/10.1017/s0033291718003057

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.